Cargando…
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Glial-origin brain tumors, including glioblastomas (GBM), have one of the worst prognoses due to their rapid and fatal progression. From an oncological point of view, advances in complete surgical resection fail to eliminate the entire tumor and the remaining cells allow a rapid recurrence, which do...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171733/ https://www.ncbi.nlm.nih.gov/pubmed/37165457 http://dx.doi.org/10.1186/s40478-023-01569-y |